TerminatedNot Applicable

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

241 participantsStarted 2007-10

Plain-language summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at previously collected and stored tissue samples from patients previously enrolled in a completed National Cancer Institute clinical trial.

Who can participate

Age range18 Years – 120 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Samples available from patients previously enrolled in one of the following terminated National Cancer Institute-Institutional Review Board clinical trials: * Phase I study of LMB-2: NCI-96-C-0064; NCI-T95-0042 * Phase I study of BL22: NCI-99-C-0014; NCI-T98-0063 * Phase I study of LMB-9: NCI-98-C-0078; NCI-T98-0005 * Phase I study of LMB-7: NCI-94-C-0172 * Phase I study of bolus SS1P: NCI-03-C-0243 * Phase I study of continuous infusion SS1P: NCI-01-C-0011 PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * See Disease Characteristics

What they're measuring

Analyses of stored human samples, specimens, and data collected from patients previously enrolled in a terminated National Cancer Institute-Institutional Review Board clinical trial

Correlation of plasma levels and pharmacokinetics with disease burden and presence of antibodies

Correlation of tumor markers with disease burden

Utility of tumor markers for following patients after treatment

Trial details

NCT IDNCT00904514

SponsorNational Institutes of Health Clinical Center (CC)

Sponsor typeNIH

Study typeOBSERVATIONAL

Primary completion2007-10

View on ClinicalTrials.gov More Cancer trials